EBAG9 and prostate carcinoma: To investigate the role of EBAG9 in the pathophysiology of prostate cancer cells, we performed functional studies using siRNA targeting EBAG9 (siEBAG9) in androgen-sensitive LNCaP and androgen-refractory DU145 cells.